|
Federal Register Notices > Notices of Registration - 2003 > Cambrex North Brunswick, Inc. Notices of Registration - 2003FR Doc 03-7838 DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Registration By notice dated March 12, 2002, and published in the Federal Register on March 25, 2002 (67 FR 13664), Chiragene, Inc., 7 Powder Horn Drive, Warren, New Jersey 07059, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of phenylacetone (8501), a basic class of controlled substance listed in Schedule II. The Company's legal name has since changed to Cambrex North Brunswick, Incorporated. The firm plans to import phenylacetone to manufacture amphetamine. Objections and a request for hearing were timely
filed and then withdrawn. DEA has considered the factors in title
21, United States Code, section 823(a) and determined that the
registration of Cambrex North Brunswick, Inc., to import phenylacetone is
consistent with the public interest and with United States obligations
under international treaties, conventions, or protocols in effect on May
1, 1971, at this time. DEA has investigated Cambrex North Brunswick, Inc.
on a regular basis to ensure that the company's continued registration is
consistent with the public interest. These investigations have included
inspection and testing of the company's physical security systems, audits
of the company's records, verification of the company's compliance with
state and local laws, and a review of the company's background and
history. Therefore, pursuant to section 1008(a) of the Controlled
Substances Dated: March 14, 2003. Laura M. Nagel, [FR Doc. 03-7838 Filed 4-1-03; 8:45 am]
Registration
Support
|
